Data / Form D filings / Sarkana Pharma, Inc.
Sarkana Pharma, Inc.: Form D filing
Sarkana Pharma, Inc., a pharmaceuticals company in Wilmington, DE, filed a Form D with the SEC in 2021. The latest, on February 17, 2021, reports $1.6 million sold of an offering with no set size to 1 investor.
Find out what Sarkana Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1000 N. WEST ST., SUITE 1200, Wilmington, DE, 19801
- Phone
- (649) 332-4417
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1845313
The full lists. Form D filings in Delaware: 1,342 rows, $67.10, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | New notice | Indefinite | $1,579,000 | Indefinite | 1 | Dec 21, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Caroline Fortier | Executive Officer | |
| Luc Marengere | Director | |
| Mark Cipriano | Executive Officer |
Every Form D from the week of Feb 15, 2021 · All recent filings in Delaware · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sarkana Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.